LOADING
On February 17, 2026, the VA published an interim final rule that would have fundamentally changed how disability ratings are calculated for veterans on medication. Here's the full breakdown.
On February 17, 2026, VA Secretary Doug Collins published an interim final rule in the Federal Register titled "Evaluative Rating: Impact of Medication." The rule directed medical examiners to base disability ratings on a veteran's actual functional impairment while on medication, rather than on the underlying severity of the condition without treatment.
In plain English: if your medication reduces your symptoms, the VA would rate you based on how you function with the medication working, not on how bad the condition actually is.
The rule was issued in response to two court decisions:
Jones v. Shinseki, 26 Vet. App. 56 (2012) — Held that the VA could not reduce ratings based on the ameliorating effects of medication for musculoskeletal conditions without specific regulatory authority.
Ingram v. Collins, 38 Vet. App. 130 (2025) — Reinforced Jones and required the VA to disregard the ameliorating effects of medication when rating musculoskeletal conditions.
The VA argued that these court decisions would force adjudicators to make assessments based on hypothetical unmedicated states, a standard the Secretary called "unquantifiable." The VA estimated the Ingram decision would require readjudication of 350,000 claims across roughly 500 diagnostic codes.
The rule was published with "immediate effect" using emergency authority, bypassing the standard 60-day congressional review period and the typical advance public comment process. Veterans, advocacy groups, and lawmakers responded immediately:
The Disabled American Veterans (DAV) called the rule "alarming" and said it "effectively shut out veterans from providing any meaningful input." The VFW's National Commander said it "could have unforeseen and harmful downstream effects for veterans." Multiple members of Congress called for the rule to be revoked. A federal lawsuit was filed in the U.S. Court of Appeals for the Federal Circuit by MilVet Law Firm and others representing 500+ veterans.
The core concern: veterans who comply with medical treatment and take their medications could see their ratings reduced, effectively penalizing them for following their doctor's orders.
Two days after publication, Secretary Collins announced the rule would not be enforced. The VA subsequently moved to formally rescind the rule, stating that "stakeholders have expressed uncertainty" about its impact and that leaving the rule in place "could undermine confidence in the benefits system."
The public comment period remains open through April 20, 2026, at regulations.gov under RIN 2900-AS49. As of this writing, more than 18,000 comments have been submitted.
If you have a pending claim: The rule is not being enforced. Your claim should be adjudicated under the existing regulatory framework (pre-February 17, 2026). If you believe your claim was affected by the brief period the rule was active, consult a VA-accredited attorney or VSO immediately.
If you're currently rated and on medication: Your current rating is not affected. The rule was formally rescinded on February 27, 2026 via Federal Register (91 FR 14203). Do not stop taking your medication. Your health comes first.
If you're filing a new claim: Continue to document your condition thoroughly. Per M21-1, Part III.iv.3.D, the VA is required to provide adequate medical examinations. Document your symptoms both with and without medication if relevant, but do not stop treatment to manipulate exam results.